Bluejay Diagnostics Announces Pricing of $3.5 Million Public Offering

<p>ACTON, Mass., Dec. 28, 2023 (GLOBE NEWSWIRE) — Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company developing rapid diagnostics on its Symphony platform to improve patient outcomes in critical care settings, today announced the pricing of a public offering of 2,692,308 shares of the Company’s common stock (or pre-funded warrants […]</p>
<p>The post <a href="https://forextv.com/top-news/bluejay-diagnostics-announces-pricing-of-3-5-million-public-offering/">Bluejay Diagnostics Announces Pricing of $3.5 Million Public Offering</a> appeared first on <a href="https://forextv.com">ForexTV</a>.</p>